MedTrace Logo

Identification of High Risk People for Colorectal Cancer and Evaluation of a Specific Surveillance System

NCT02931825 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7101

Last updated 2019-05-30

No results posted yet for this study

Summary

Colorectal cancer is one the most frequent cancer in developed countries. In France, it rank third with 43000 new cases in 2015. French Health Authority recommended colonoscopy screening for people with a high risk for colorectal cancer. But this compliance with colonoscopy is low (20-40%), it is therefore necessary to develop new strategies to improve compliance.

The purpose of this project is to to offer and evaluate the feasibility and the effectiveness of a specific surveillance system for high risk people for colorectal cancer

The project will be divided into 2 phases:

Objectives of the first phase:

* Identify high risk people for colorectal cancer in the department of Indre-et-Loire,
* Fill in as completely as possible their colonoscopic history in the past 5 years,
* Estimate the proportion of high risk people for colorectal cancer in the target population for colorectal cancer screening in Indre-et-Loire (Men and women aged from 50 to 74 years).

Objective of the second phase:

Compare the performed colonoscopy rate of high risk people for colorectal cancer without notion of colonoscopy in the past 58 months following or not (control group) the sending of a letter reminding the importance of compliance with colonoscopy.

Conditions

  • Cancer Colorectal

Interventions

BEHAVIORAL

Reminder letter

The letter will consist in several parts: * Reminder of : -the need of individual follow-up for high risk people for colorectal cancer AND - the general recommendations (one colonoscopy every 5 years) * Recommendation to consult their general practitioner or gastroenterologist if they haven't done their follow up * Request information if they've done their follow-up or if we have incorrect information * Indication that the letter is sent as part of a surveillance program specific for high risk people for colorectal Cancer

Sponsors & Collaborators

  • University Hospital, Tours

    lead OTHER

Principal Investigators

  • Somany SENGCHANH, Dr · Centre de Coordination des Dépistages des Cancers CHRU de Tours

  • Ken HAGUENOER, Dr · Centre de Coordination des Dépistages des Cancers

  • Julie Boyard · Centre de Coordination des Dépistages des Cancers

  • Thierry Lecomte, Pr · CHRU de Tours, Service Hépato- gastroentérologie

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-23
Primary Completion
2018-05-23
Completion
2019-05-23

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02931825 on ClinicalTrials.gov